Inhibrxinc Stock Net Income
| INBX Stock | USD 34.74 0.24 0.69% |
InhibrxInc fundamentals help investors to digest information that contributes to InhibrxInc's financial success or failures. It also enables traders to predict the movement of InhibrxInc Stock. The fundamental analysis module provides a way to measure InhibrxInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InhibrxInc stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -130.7 M | -124.2 M | |
| Net Loss | -188.7 M | -179.2 M | |
| Net Loss | -241.4 M | -229.3 M | |
| Net Loss | (5.12) | (5.38) | |
| Net Income Per E B T | 1.01 | 0.79 |
InhibrxInc | Net Income |
InhibrxInc Company Net Income Analysis
InhibrxInc's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current InhibrxInc Net Income | (241.36 M) |
Most of InhibrxInc's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InhibrxInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
InhibrxInc Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for InhibrxInc is extremely important. It helps to project a fair market value of InhibrxInc Stock properly, considering its historical fundamentals such as Net Income. Since InhibrxInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of InhibrxInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of InhibrxInc's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
InhibrxInc Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, InhibrxInc reported net income of (241.36 Million). This is 170.72% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 142.27% higher than that of the company.
InhibrxInc Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InhibrxInc's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InhibrxInc could also be used in its relative valuation, which is a method of valuing InhibrxInc by comparing valuation metrics of similar companies.InhibrxInc is currently under evaluation in net income category among related companies.
InhibrxInc Institutional Holders
Institutional Holdings refers to the ownership stake in InhibrxInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of InhibrxInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing InhibrxInc's value.| Shares | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 956.9 K | Sofinnova Ventures | 2023-12-31 | 773 K | Capital Research Global Investors | 2023-12-31 | 712.4 K | Bank Of America Corp | 2023-12-31 | 693 K | Geode Capital Management, Llc | 2023-12-31 | 687.4 K | Northern Trust Corp | 2023-12-31 | 313.9 K | Goldman Sachs Group Inc | 2023-12-31 | 306.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 296.9 K | Partner Fund Management Lp | 2023-09-30 | 288.6 K | Viking Global Investors Lp | 2023-12-31 | 7.2 M | Ra Capital Management, Llc | 2023-12-31 | 4.7 M |
InhibrxInc Fundamentals
| Return On Equity | -4.75 | ||||
| Return On Asset | -0.46 | ||||
| Operating Margin | (54.03) % | ||||
| Current Valuation | 1.59 B | ||||
| Shares Outstanding | 47.39 M | ||||
| Shares Owned By Insiders | 19.57 % | ||||
| Shares Owned By Institutions | 86.53 % | ||||
| Number Of Shares Shorted | 2.15 M | ||||
| Price To Book | 38.11 X | ||||
| Price To Sales | 920.99 X | ||||
| Revenue | 1.8 M | ||||
| Gross Profit | (107.99 M) | ||||
| EBITDA | (218.03 M) | ||||
| Net Income | (241.36 M) | ||||
| Cash And Equivalents | 176.38 M | ||||
| Cash Per Share | 4.52 X | ||||
| Total Debt | 210.14 M | ||||
| Debt To Equity | 4.22 % | ||||
| Current Ratio | 7.51 X | ||||
| Book Value Per Share | 0.92 X | ||||
| Cash Flow From Operations | (193.31 M) | ||||
| Short Ratio | 3.41 X | ||||
| Earnings Per Share | (5.12) X | ||||
| Target Price | 35.5 | ||||
| Number Of Employees | 166 | ||||
| Beta | 2.92 | ||||
| Market Capitalization | 1.66 B | ||||
| Total Asset | 307.89 M | ||||
| Retained Earnings | (613.73 M) | ||||
| Working Capital | 239.05 M | ||||
| Net Asset | 307.89 M |
About InhibrxInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InhibrxInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InhibrxInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InhibrxInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out InhibrxInc Piotroski F Score and InhibrxInc Altman Z Score analysis. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.